The use of the anti-inflammatory drug colchicine in an outpatient setting may reduce the risk of COVID-19–related death or hospitalization in patients with PCR-confirmed COVID-19, according to results of the phase III COLCORONA* trial.
The installation of a decentralized contact tracing app (CTA) for COVID-19 is driven by concern for one’s own health, but concern for others does not significantly predict app uptake over and above self-focused concern, a recent study suggests.
More than 8 months since the first COVID-19 vaccine is made available to the masses, the world has held the hope of a return to normalcy just to see it dashed again with the recent surge in COVID-19 cases.
Wearing a surgical face mask provides a high protective effect against aerosols while posing low airflow resistance, in contrast to plastic face shields which offer little to no protection, a study reveals.
Daily use of a mouthwash which has demonstrated inhibition of Neisseria gonorrhoeae (N. gonorrhoeae) growth in vitro did not reduce the risk of oropharyngeal gonorrhoea in men who have sex with men (MSM), according to results of the OMEGA* study from Australia.
Some factors associated with rheumatoid arthritis (RA), such as treatment with leflunomide, azathioprine, and prednisolone and concomitant obstructive lung disease, can elevate the risk of tuberculosis (TB) in biologic-naïve patients with RA, reveals a study.
Most symptomatic children who tested positive for SARS-CoV-2 recovered within a week, and only a small subset of children experienced lingering symptoms in the COVID Symptom Study, one of the largest UK citizen participatory epidemiological studies thus far.